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Abstract
Background: Tumour necrosis factor (TNF) is crucial for the control of mycobacterial infection
as TNF deficient (KO) die rapidly of uncontrolled infection with necrotic pneumonia. Here we
investigated the role of membrane TNF for host resistance in knock-in mice with a non-cleavable
and regulated allele (mem-TNF).
Methods: C57BL/6, TNF KO and mem-TNF mice were infected with M. tuberculosis H37Rv (Mtb
at 100 CFU by intranasal administration) and the survival, bacterial load, lung pathology and
immunological parameters were investigated. Bone marrow and lymphocytes transfers were used
to test the role of membrane TNF to confer resistance to TNF KO mice.
Results: While TNF-KO mice succumbed to infection within 4–5 weeks, mem-TNF mice
recruited normally T cells and macrophages, developed mature granuloma in the lung and
controlled acute Mtb infection. However, during the chronic phase of infection mem-TNF mice
succumbed to disseminated infection with necrotic pneumonia at about 150 days. Reconstitution
of irradiated TNF-KO mice with mem-TNF derived bone marrow cells, but not with lymphocytes,
conferred host resistance to Mtb infection in TNF-KO mice.
Conclusion: Membrane expressed TNF is sufficient to allow cell-cell signalling and control of
acute Mtb infection. Bone marrow cells, but not lymphocytes from mem-TNF mice confer
resistance to infection in TNF-KO mice. Long-term infection control with chronic inflammation
likely disrupting TNF mediated cell-cell signalling, additionally requires soluble TNF.
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Protective immunity to M. tuberculosis (Mtb) infection is
regulated by T cells, macrophages and cytokines including
IFNγ, IL-12 and TNF [1,2]. IFNγ derived from T and NK
cells has been shown to be essential, as mice with a dis-
ruption of the IFNγ signalling are unable to restrict the
growth of M. tuberculosis and succumb to the infection [3-
6]. A critical role for TNF in mycobacterial defence was
inferred from neutralisation and gene deletion experi-
ments in mice [7-10]. TNF neutralising therapies for rheu-
matoid arthritis and Crohn's disease turned out to
increase the risk of developing tuberculosis (TB) and other
opportunistic infections [11-14].
TNF produced by macrophages, and a variety of other
cells, is a major regulator of inflammation and leukocyte
trafficking [15,16]. Although soluble TNF in controlling
intracellular bacterial infections is uncontested, the func-
tion of membrane TNF, which is subsequently cleaved by
the metalloproteinase-disintegrin TACE (TNFα convert-
ing enzyme) [17] into the secreted trimeric TNF, is not
established. Several biological functions of membrane
TNF have been described, such as strong cytotoxity, poly-
clonal activation of B cells, induction of IL-10 by mono-
cytes, ICAM-1 expression on endothelial cells and
regulation of chemokine expression [18,19]. The trans-
genic overexpression of membrane TNF (mem-TNF) dem-
onstrated an in vivo role in the control of Listeria and
mycobacterial infection [20,21]. However these studies
have been performed on TNF/lymphotoxin (LT) deficient
background, and since lymphotoxin is implicated into TB
resistance, do not address the role of membrane TNF only
[20,21]. The recent generation of a mouse with functional,
normally regulated and expressed membrane-bound TNF,
obtained by knocking-in an uncleavable ∆1–9,K11E TNF
allele, represents a major advance and allowed interesting
insights in the role of membrane TNF in lymphoid struc-
ture maintenance and inflammation [19].
Here we asked whether membrane TNF is sufficient for
containing Mtb infection. We compared the host resist-
ance to acute mycobacterial infection in mem-TNF mice,
eg. ∆1–9,K11E TNF knock-in mice [19], and TNF-deficient
(TNF-KO) mice [22]. We show that membrane TNF sub-
stitutes soluble TNF to recruit and activate macrophages
and T cells, to generate granuloma and control acute infec-
tion, but is insufficient to control the chronic phase of
infection. Transfer of bone marrow cells, but not of lym-
phocytes from mem-TNF and WT mice was able to confer
resistance to infection in TNF KO mice.
Methods
Mice
Mem-TNF [19] and TNF-KO mice [22] on a C57BL/6
background and C57BL/6 mice were bred in house. For
experiments, adult (8–15 week old) animals were kept in
sterile isolators in a biohazard animal unit. All animal
experiments complied with the French Government's eth-
ical and animal experiment regulations.
Bacteria and infection
Pulmonary infection with M. tuberculosis H37Rv (Pasteur)
was performed by delivering 100 bacteria into both nasal
cavities (20 µl each) under xylazine-ketamine anaesthesia
as described [23]. The bacterial load in the lung was deter-
mined at day 1 post infection. Three independent experi-
ments were conducted, one short term for 90 days, a long-
term study over 240 days (n = 6 per group) and a second
long-term study over 200 days (n = 10 mice per group).
Bacterial load in tissues and histological investigation
Bacterial loads in organs of infected mice were evaluated
at different time points after infection with M. tuberculosis
H37Rv as described [23]. For histological analysis lungs
were fixed in 4% phosphate buffered formalin, paraffin-
embedded as described, and stained with haematoxylin
and eosin and a modified Ziehl-Neelsen [10].
FACS analysis of infiltrating cells from infected lung
FACS analysis of inflammatory cells from infected lung
was performed as described [23,24]. Rat anti-mouse CD4-
PerCP (clone RM4-5), CD8-FITC (clone 53-6.7), Ly6G-PE
(clone RD6-8C5), CD11b-PE (clone M1/70), I-A/I-E-
FITC (clone 2G9) were from BD Pharmingen (San Diego,
CA) and stained cells were analyzed by flow cytometry on
a LSR analyser (Becton Dickinson).
Cytokine determination
IL-12p40 and IFNγ were quantified using commercial
ELISA (Duoset, R&D Systems, Abingdon, UK). Bioactive
TNF was assessed using the WEHI 164 cells based bioassay
[25].
Reconstitution of irradiated mice with lymphocytes or 
bone marrow cells of TNF KO mice
Haemopoietic reconstitution of bone marrow was per-
formed as described [26]. Briefly, designated recipient
mice received an optimised lethal total body irradiation
dose of 8 Grey using a γ-irradiation source (CHRO, Orle-
ans). Irradiated mice were reconstituted with 2 × 106 fresh
unseparated bone marrow cells by intravenous injection
in the lateral tail vein (n = 6 per group). Mice were left to
fully reconstitute for at least three month prior to infec-
tion, reconstitution was verified by the analysis of the hae-
matogram. In addition, freshly isolated splenic T
lymphocytes (107 i.v.) from WT and mem-TNF mice were
transferred into TNF KO mice (exposed to 4 Grey γ-irradi-
ation) immediately before Mtb infection and survival was
followed (n = 6 per group). The experiments were
repeated once.Page 2 of 9
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Murine bone marrow cells were isolated from femurs and
differentiated into macrophages using 20% horse serum
and 30% L929 cell-conditioned medium as a source of M-
CSF [26]. Alternatively, murine bone marrow cells were
differentiated into myeloid dendritic cells using 4% J558L
cell-conditioned medium as a source of GM-CSF [27].
Stimulation of macrophages and dendritic cells
Bone marrow derived macrophages (BMDM) and den-
dritic cells (BMDC) were plated (at 105 cells/well) and
stimulated with LPS (Escherichia coli, serotype O111:B4,
Sigma, St Louis, MO, at 100 ng/ml) or M. tuberculosis
H37Rv (heat-killed 40 min at 80°C; 2 bacteria per cell), or
infected with M. bovis BCG (Pasteur Institute, at a MOI of
2 bacteria per cell) as described before [28]. Cell superna-
tants were harvested after 24 h of stimulation in the pres-
ence of IFNγ (100 U/ml) for TNF and IL-12 p40
quantification, and nitrite measurements by Griess rea-
gents [29]. Membrane expressed CD40 and CD86 stain-
ing was performed as described [28] using CD40-PE
(clone 3/23) and CD86-FITC (clone GL1, BD PharMingen
San Diego, CA). The mean fluorescence of non-stimulated
and activated macrophages was compared.
Antigen-specific IFNγ production
T cell priming was assessed by the production of IFNγ
upon antigen restimulation ex vivo as described [23]. Sin-
gle cell suspension of splenocytes and mediastinal lymph
nodes were prepared from mice 4 weeks after infection.
Cells were stimulated with either 2.5 µg/ml Con A
(Sigma), a lyophilised soluble fraction from BCG culture
supernatant (SupBCG, 10 µg/ml), or heat killed Listeria
monocytogenes (100 bacteria per cell) for 3 days at 37°C
as described [28]. IFNγ production in the supernatant was
quantified by ELISA.
Statistical Analysis
ANOVA was used for the analysis of the early data points
for the comparison of three experimental groups. For the
data points beyond one month we used the Student's t
test. Survival data (Kaplan Meier plots) were compared
using a log rank test for the comparison of the groups. A p
value <0.05 was considered statistically significant.
Results
Absence of secreted TNF in mem-TNF mice
To confirm that mem-TNF mice do not secrete TNF, serum
was obtained 90 min after LPS (100 µg) injection. In con-
trast to WT mice TNF was undetectable in the sera of both
TNF-KO and mem-TNF mice (not shown). While bone
marrow derived macrophages (BMDM) secrete high TNF
levels in response to M. bovis BCG and Mtb infection or to
LPS, TNF is undetectable in culture supernatants of
BMDM from TNF-KO and strongly defective in mem-TNF
mice (Fig 1A), the latter however express TNF on the
membrane of activated macrophages and T-cells as shown
before [19]. Interestingly, the production of IL-12p40 was
augmented in TNF-KO as compared to WT macrophage,
but normalised in mem-TNF macrophages (Fig 1B).
Therefore, membrane-bound TNF is sufficient to normal-
ise IL12p40 production by macrophages, while complete
absence of TNF results in deregulated IL12p40 expression
as described before [30]. The production of IL-6 and
nitrites was essentially unaffected in stimulated mem-TNF
macrophages, as compared to WT or TNF-KO macro-
phages (data not shown). Second, mycobacteria-induced
expression of costimulatory molecules CD40 and CD86
was investigated in BMDM and BMDC. CD40 and CD86
upregulation was induced to a comparable extent in mac-
rophages (Fig 1C,D) and dendritic cells (data not shown)
in all groups as compared to unstimulated controls indi-
cating that the expression of costimulatory molecules is
TNF independent. Taken together, these observations
confirm the defective secretion of functional TNF in vivo
and in vitro in mem-TNF mice, while the expression IL-12
and costimulatory molecules were unaffected.
Membrane TNF is sufficient to control acute M. 
tuberculosis infection
To ascertain the role of soluble vs membrane-bound TNF
in resistance to tuberculosis, we compared mem-TNF,
TNF-KO mice and WT mice infected with 100 CFU Mtb
given by intranasal administration. Within 4–5 weeks of
Defective soluble TNF and augmented IL-12 production from mycobacterial stimulated macrophages, and normal upregula-tion of CD40 and CD86 costi ula ory moleculesFigure 1
Defective soluble TNF and augmented IL-12 produc-
tion from mycobacterial stimulated macrophages, 
and normal upregulation of CD40 and CD86 costim-
ulatory molecules. Mycobacteria induced TNF (A) and IL-
12p40 (B) production at 24 h TNF in the supernatant of mac-
rophages from WT (open bars), TNF-deficient (black bars) 
and mem-TNF mice (grey bars) infected with BCG or H37Rv 
(at a MOI of 2) or stimulated with LPS (100 ng/ml). Data are 
expressed as the mean ± SD (n = 2 mice from one out of 4 
independent experiments). TNF independent expression of 
costimulatory molecules CD40 (C) and CD86 (D) analysed 
by flow cytometry in macrophages stimulated as above. 
Results are expressed as mean percentage.Page 3 of 9
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shown), impeded locomotor activity and succumbed to
infection rapidly (Fig 2A). Mem-TNF mice had normal
weight development and survived the 90 days observation
period. Therefore, we conclude that membrane bound
TNF confers substantial protection to acute Mtb infection.
The relative lung weights -a surrogate marker of inflam-
mation- of surviving TNF-KO mice at 30 days were
increased (p < 0.01), but not in WT and only slightly in
mem-TNF mice (Fig 2B). Lungs of TNF-KO mice displayed
large nodular and confluent lesions on the pleura at 30
days post infection, which were much smaller and more
discrete in mem-TNF mice, comparable to those in WT
mice (Fig. 2C).
We then determined the mycobacterial load in the lungs.
At 30 days WT mice displayed a 4 log increase of viable
mycobacteria reaching 106 CFU counts in the lungs (Fig
2D), which stabilises thereafter, as shown before [24]. By
contrast, bacillary burden in the lung was significantly
increased in TNF-KO mice (p < 0.01) reaching a value of
109 CFU, while mem-TNF had comparable CFU values as
WT mice (Fig 2D). Mtb dissemination measured by
splenic and hepatic bacterial loads was also significantly
increased in TNF-KO mice, but not in mem-TNF mice
(data not shown). Therefore, acute Mtb infection is con-
trolled in the presence of membrane TNF only.
The establishment of granulomas is the manifestation of
a vigorous cell mediated immune response, which is cru-
cial for inhibiting mycobacterial growth and depends on
TNF [31]. We asked whether membrane bound TNF is suf-
ficient for granuloma formation upon Mtb infection. At
30 days post infection the lungs of mem-TNF mice dis-
played well-defined granulomatous lesions that were
characterised by foamy epitheloid like macrophages with
surrounding and interspersed and perivascular lym-
phocytic infiltration, similar to the granuloma structures
formed in WT mice (Fig 2E). TNF-KO mice had abundant
inflammatory cells with extensive necrosis, and no struc-
tured granuloma. Therefore, membrane TNF is sufficient
for granuloma formation and infection control.
Membrane TNF allows lymphocyte recruitment and cell 
activation upon mycobacterial infection
In view of the granulomatous response elicited in mem-
TNF mice after Mtb infection we investigated whether
membrane TNF could affect the cellular recruitment in the
lungs. Single cell suspension of lung infiltrating cells was
obtained at 30 days post infection. CD4 and CD8 lym-
phocytes were significantly higher in TNF-KO than in WT
mice (p < 0.01), in line with the severe pathology in these
mice, while the sole presence of mem-TNF prevented the
augmented lymphocyte recruitment as shown in mem-
TNF mice (Fig. 3A,B). Enhanced cell mediated immune
responses have been shown in the complete absence of
TNF [32] and is probably linked to uncontrolled bacterial
growth in TNF-KO mice, leading to excessive inflamma-
tion. We show that the presence of membrane TNF cor-
rects the TNF-deficient phenotype, i.e. cellular recruitment
to the infected lungs was normal. Concomitant with
increased lymphocyte recruitment IFNγ levels in lung
homogenates from TNF-KO mice were significantly
Necrotic pneumonia and uncontrolled infection in TNF-KO mice, but not in mem-TNF mice at 30 days after Mtb infec-tion (100 CFU, intr n sal ad i istration)Figure 2
Necrotic pneumonia and uncontrolled infection in 
TNF-KO mice, but not in mem-TNF mice at 30 days 
after Mtb infection (100 CFU, intranasal administra-
tion). Survival (A), relative lung weights (B), macroscopic 
lung changes (C), and bacterial load at 30 days in the lungs 
(D). The results are expressed as the mean ± SD (n = 6 per 
group) and are representative of two independent experi-
ments. The bacterial load at day 1 upon infection was 84 ± 28 
CFU per lung (n = 6). Microscopic investigations of the lungs 
show confluent neutrophil and mononuclear cell inflamma-
tion with extensive, confluent necrosis and abundant bacilli in 
TNF-KO mice, while mem-TNF and WT mice show focal, 
largely perivascular mononuclear cell infiltration (E). Repre-
sentative haematoxylin and eosin stained lung sections at low 
(50×) and high power (200×) are shown (n = 5 per group).Page 4 of 9
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contrast, lungs from mem-TNF mice showed comparable
amounts of IFNγ as WT mice.
We then asked whether a mycobacteria-specific T cell
response is acquired in mem-TNF and TNF-KO mice. Ex
vivo restimulation 30 days after infection of splenic lym-
phocytes (Fig. 3D) with mycobacterial antigens (Sup-
BCG), but not with an irrelevant antigen, induced IFNγ
secretion in cells from both TNF-KO and mem-TNF mice.
Although IFNγ levels were significantly higher in TNF-KO
as compared with WT (p < 0.01), the IFNγ levels of mem-
TNF mice did not differ from those of infected WT mice.
These data suggest that membrane TNF allows substantial,
but controlled recruitment and activation of T cells and
macrophages resulting in mycobactericidal effector mech-
anisms. The acquisition of an antigen specific immune
response as assessed by the production of IFNγ is TNF
independent.
Membrane TNF is unable to confer long-term protection 
against Mtb infection
While acute infection was controlled by the expression of
membrane TNF (Fig. 2), absence of soluble TNF might
affect the control of chronic infection, as we have shown
in other conditions [24]. Conversely, in TLR2 [33] or
TLR4 deficient mice [34] acute, but not chronic infection
is controlled. We therefore conducted a long-term infec-
tion study in mem-TNF mice and compared it to WT mice
infected with 100 CFU (intranasal route), a condition
where TNF-KO mice die within 4–5 weeks (Fig. 2A)
[10,23]. While mem-TNF mice appeared healthy over four
months, they started to loose body weight and succumbed
to infection between 130 – 170 days (Fig. 4A). At 112
Augmented CD4 and CD8 T cell recruitment, pulmonary IFNγ production and antigen-specifi  T cell res onse in infect d TNF-KO mice are corrected in m-TNF miceFigur  3
Augmented CD4 and CD8 T cell recruitment, pul-
monary IFNγ production and antigen-specific T cell 
response in infected TNF-KO mice are corrected in 
mem-TNF mice. Recruitment of CD4 (A) and CD8 T cells 
(B) in the lung of WT, mem-TNF and TNF-KO mice infected 
with Mtb (100 CFU). Lymphocytes were obtained form lungs 
from Mtb infected mice at 30 days post infection as described 
in Materials and Methods. IFNγ levels in lung homogenates at 
30 days of infection (C): Increased IFNγ levels in TNF KO 
mice, which were lower and comparable in mem-TNF and 
WT mice. Antigen-specific IFNγ production by SupBCG res-
timulated splenocytes from mem-TNF and TNF-KO mice, 
but augmented response in TNF-KO splenocytes (D). Data 
are representative of two independent experiment (n = 4 
mice, mean ± SD).
Mem-TNF mice succumb of uncontrolled chronic Mtb infec-tion after 4–6 monthsFigure 4
Mem-TNF mice succumb of uncontrolled chronic 
Mtb infection after 4–6 months. Survival (A) of infected 
mice (Mtb 100 CFU given by intranasal route), data two inde-
pendent experiments (n = 16 per group). Organs weights (B) 
and bacterial loads (CFU) in lungs (C) and spleen (D) were 
determined at 112 days after infection. The results are 
expressed as the mean ± SD (n = 6 per group). Microscopic 
changes of the lung from mem-TNF and WT mice at 112 
days (E). Microscopic analysis of the lung reveal a more abun-
dant macrophages and lymphocyte infiltration in mem-TNF 
mice with confluent foci and less defined granulomatous 
lesions. Representative haematoxylin and eosin stained lung 
sections at low (50×) and high power (200×) are shown (n = 
6 per group).Page 5 of 9
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inflammation and pathology were significantly increased
in mem-TNF mice (Fig. 4B) and viable mycobacteria in
lungs were almost two logs higher (Fig. 4C), reaching 107
CFU, a bacterial load still much lower than that observed
in moribund TNF-KO mice after 30 days of infection (Fig.
2D). Bacterial dissemination was also increased (Fig. 4D).
Mycobacterial cultures obtained from lungs from mori-
bund mem-TNF mice sacrificed at later time points indi-
cated a further increase of CFU in the lungs (not shown).
The microscopic investigation revealed a more abundant
macrophages and lymphocyte infiltration in mem-TNF
mice with confluent foci and less defined granulomatous
lesions at 112 days (Fig. 4E). Therefore, lack of soluble
TNF may allow slow growth of mycobacteria during the
chronic infection, with likely progressive hypoxemia due
to chronic pneumonia, leading to death in the chronic
phase of infection.
Reconstitution of TNF deficiency by bone marrow 
transplantation
First we attempted to confer resistance in irradiated TNF
KO mice to acute Mtb infection by the transfer of lym-
phocytes from mem-TNF mice. Neither lymphocytes from
mem-TNF nor WT mice increased survival in TNF KO
mice (data not shown), which is at variance with the
recent data from Saunders et al. [37].
Since TNF derived from hemopoietic cells likely contrib-
utes most of bioactive TNF [35] and we have shown
before that bone marrow transplantation confers resist-
ance to TNF-KO mice to BCG infection [36], we asked
whether membrane expressed TNF on haemopoietic cells
might be sufficient to correct the susceptibility to Mtb
infection of TNF-KO mice. Lethally irradiated TNF-KO
mice reconstituted with bone marrow cells from mem-
TNF mice controlled Mtb infection as demonstrated by
survival over three months, while TNF-KO mice suc-
cumbed to acute necrotic pneumonia within 40 days (Fig.
5A). Similarly, irradiated TNF-KO reconstituted with WT
bone marrow survived the whole experiment. Although
TNF-KO mice could not contain the infection, reconsti-
tuted TNF-KO mice developed granuloma (data not
shown) and were able to control acute infection and bac-
terial growth in the lungs (Fig. 5B). Therefore, bone mar-
row derived cells expressing membrane TNF, but not
lymphocytes, are sufficient to control infection in recon-
stituted TNF-KO mice.
Discussion
We report that membrane TNF plays a crucial role in the
control of mycobacterial infection using a knock-in
mouse model where the endogenous TNF allele was
replaced by a non-cleavable membrane TNF (mem-TNF)
mutated in the TACE cleavage site [19]. The expression of
mutated membrane TNF confers protection against acute
mycobacterial infection with initial control of mycobacte-
rial growth and normal granuloma development in the
lung. However, long-term control of infection appears to
be dependent additionally on soluble TNF, as mem-TNF
mice eventually succumb to chronic infection as shown
by a recent contribution [37]. However, we show here sig-
nificant differences such as uncontrolled infection in the
late phase with disseminating infection and the capacity
of membrane expressing cells from the bone marrow to
confer long-term -and not transient- resistance to Mtb
infection in TNF deficient recipient mice.
A critical role of TNF for the effective control and resolu-
tion of mycobacterial infection has been demonstrated
previously [7,10,24], which is mediated by TNFR1 [9],
rather than TNFR2 signalling [38]. TNF provided by
recombinant BCG expressing TNF may reconstitute gran-
uloma formation and host response in TNF-KO, but not
Bone marrow cells from mem-TNF mice correct the height-ened susceptibility of TNF deficientFigure 5
Bone marrow cells from mem-TNF mice correct the 
heightened susceptibility of TNF deficient mice. Long-
term survival of TNF-KO mice reconstituted with bone mar-
row from mem-TNF or WT mice (A), and control of infec-
tion in the lung (B) of bone marrow reconstituted TNF-KO 
mice (p < 0.01). Lethally irradiated (8 Grey) and reconsti-
tuted TNF-KO were exposed to infection (Mtb 100 CFU, 
intranasal administration) 4 months after irradiation and 
bone marrow reconstitution. The results are expressed as 
mean values ± SD (n = 6).Page 6 of 9
(page number not for citation purposes)
Respiratory Research 2005, 6:136 http://respiratory-research.com/content/6/1/136in TNFR1-KO mice, demonstrating the critical role of TNF
and TNFR1 signalling [39]. Overexpressed membrane
TNF conferred partial resistance to Listeria and mycobac-
terial infection in transgenic mice on a TNF deficient [20]
or on a TNF-LTα double deficient background [21,40].
However, transgenic expression of mem-TNF results in
artificially high, non-regulated and non-selective expres-
sion of membrane TNF which may make conclusions on
the physiological function difficult. While Saunders et al
[37] using the same genetic model demonstrate death
during the chronic phase, we show here that the bacterial
load in lung and spleen is augmented significantly within
3 month of infection with disseminated infection (Fig
4C,D) and increases further in the mice dying with
necrotic pneumonia.
The mechanism how membrane TNF confers protection
may be due to cell-to-cell contacts of T cells, macrophages
and other cells and needs further investigations. Several
biological functions of membrane TNF have been
reported previously and a preferential TNFR2 signalling
has been suggested in vitro [18], while in vivo both
TNFR1 and TNFR2 were reported to contribute to the sig-
nalling by membrane bound TNF [21,41-43]. Since
TNFR1 is crucial for the resistance against TB infection,
our study suggests memTNF -> TNFR1 signalling as
important for host defence. Furthermore, membrane TNF
has been shown to be involved in reverse (outside-to-
inside) signalling. Upon ligation of its receptor mem-TNF
expressing cells are activated to express E-selectin [44].
Thus, membrane TNF at least in T cells might function as
a bipolar positive regulator of inflammation either trans-
mitting signals as a ligand to target cells or receiving sig-
nals through membrane TNF itself into T cells.
Membrane TNF is sufficient for the development of gran-
ulomas. In the absence of TNF there was no formation of
well-defined granulomas [7,36]. Neutralisation of TNF by
antibodies, which likely affects also membrane TNF, leads
to the disruption of established granulomas and uncon-
trolled infection [31]. Activated macrophages expressing
iNOS in granuloma are critical for bacterial killing [45-
47]. iNOS expression is reduced in lungs of infected TNF-
KO mice as compared to mem-TNF and WT mice (data
not shown), which has been confirmed [21,40]. Further,
the transfer of bone marrow cells expressing mem-TNF is
sufficient to correct the increased susceptibility of TNF-KO
mice, which clearly points to hemopoietic cells being crit-
ically involved in host resistance, and corroborates our
previous data using WT bone marrow cells to correct the
TNF-KO phenotype [36]. By contrast, we were unable to
confer host resistance to TNF KO mice by passive transfer
of mature lymphocytes as reported recently [37]. There-
fore, sustained membrane expressed TNF on myeloid and
lymphoid cells may be necessary to control infection.
Interestingly, lymphocyte recruitment was lower and
comparable in mem-TNF mice and WT mice (Fig. 3A,B)
unlike in the absence of TNF. Augmented lymphocyte
recruitment with expansion of activated CD4 and CD8 T
cells in the complete absence of TNF has been reported
before [32]. Since the expression of costimulatory mole-
cules (Fig. 1C,D) was normal in the absence of TNF, we
tested the adaptive immune response. Lymphocytes form
infected mem-TNF mice had normal antigen-induced
INF-γ response, comparable to that of WT mice (Fig. 3D),
suggesting a normal adaptive immune response, while the
response was augmented in TNF deficient T cells, in line
with previous findings [32]. CD4+ T-cells are critical for
cell mediated immunity [1], but not sufficient as shown
before for MyD88 deficiency [23].
Finally, the question arises why mem-TNF mice succumb
in the chronic phase of infection. It may be hypothesized
that membrane expressed TNF activates macrophages in
the absence of soluble TNF to a certain level, but the kill-
ing may not be as effective as in WT macrophages.
Secreted TNF and hence distal signalling is likely required
in the chronic phase where direct cell contact between T
cells and macrophages may be more difficult to achieve in
the chronic inflammatory and fibrotic tissue and therefore
soluble TNF may be more efficient to maintain the activa-
tion of the innate host defence.
Conclusion
Membrane expressed TNF allows cell-cell signalling and
control of acute Mtb infection. Bone marrow cell reconsti-
tution, but not lymphocyte transfer from mem-TNF mice
confer resistance to infection in TNF-KO mice. Long-term
infection control, however, with chronic inflammation
disrupting TNF mediated cell-cell signalling, requires
additionally soluble TNF.
The data are of clinical significance, as neutralising thera-
pies used to treat patients with rheumatoid arthritis may
reactivate latent TB infection [11]. TNF blockers have dif-
ferent capability to inactivate TNF, anti-TNF antibodies
(infliximab, remicade) binding both soluble and mem-
brane bound TNF, whereas soluble TNFR2 (etanercept)
binding preferentially soluble TNF [14]. Therefore novel
strategies to disrupt more selectively the TNF – TNF-R
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